About
Rashika Bansal, MD, DABOM, FACE is a board-certified endocrinologist and the Co-founder and Medical Director of Halt Clinic. She holds triple board certification: Endocrinology, Diabetes and Metabolism (ABEM, 2022), Obesity Medicine (ABOM, 2023), and Internal Medicine (ABIM, 2018). She also holds Fellowship in the American College of Endocrinology.
She earned her M.B.B.S. at B.J. Medical College in Pune, India, graduating as Gold Medalist and ranking first in her state at Maharashtra University of Health Sciences. She completed her Internal Medicine residency at St. Joseph's Regional Medical Center and New York Medical College in Paterson, NJ. Her endocrinology fellowship took place at the National Institutes of Health, where she trained within the NIDDK and NICHD divisions and served as Co-Investigator on a long-term natural-history study of hyperparathyroidism and MEN1 syndrome. After the NIH, she joined the Cleveland Clinic Endocrine and Metabolism Institute as a Professional Staff Endocrinologist and Clinical Assistant Professor at Cleveland Clinic Lerner College of Medicine. She now serves as Assistant Professor at Rutgers Robert Wood Johnson Medical School, where she leads the Metabolic and Weight-Management Clinic. Her active research investigates tirzepatide for treating insulin resistance in congenital generalised lipodystrophy, with IRB approval from Rutgers RWJMS in 2025. She has authored 13 peer-reviewed publications and presented at ENDO, AACE, IASLC, and ISUOG. Dr. Bansal approaches every patient by reading the full trajectory of their labs, not just the most recent values. She tells patients plainly when their endocrine system is not the source of their symptoms and refers them to the right clinician when appropriate.
Education & Training
Medical School
B.J. Medical College, Pune, India — M.B.B.S., 2007–2013 (Gold Medalist, Rank 1 in first-year M.B.B.S. at state level, Maharashtra University of Health Sciences)
Residency
Internal Medicine — St. Joseph's Regional Medical Center / New York Medical College, Paterson, NJ, 2015–2018
Fellowship
Endocrinology & Metabolism — National Institutes of Health (NIDDK/NICHD), Bethesda, MD, 2018–2021
Additional Training
Clinical & Research Fellow, NIDDK/NICHD, NIH (2018–2021); Associate Investigator, Physical and Behavioral Traits of Overweight and Obese Adults study; Co-Investigator, long-term natural-history protocol in hyperparathyroidism and MEN1 syndrome
Certifications
Conditions Treated
Who is Dr. Bansal right for?
Dr. Bansal works well with adults who have received normal lab results but continue to experience symptoms like fatigue, weight changes, hair loss, or irregular cycles. Patients managing thyroid disease, PCOS, insulin resistance, prediabetes, or metabolic syndrome benefit from her dual expertise in endocrinology and obesity medicine. She also serves men with low testosterone and adults navigating perimenopause or menopause. Patients preparing for conception who need thyroid or metabolic optimization before or during fertility treatment are a strong fit. Those with complex or rare endocrine conditions, including lipodystrophy, MEN1, adrenal disorders, or hyperparathyroidism, will find her NIH research background directly relevant.
Frequently Asked Questions
Dr. Bansal treats thyroid disease, PCOS, insulin resistance, prediabetes, type 2 diabetes, metabolic syndrome, perimenopause, menopause, low testosterone, and male hypogonadism. She also manages complex and rare endocrine conditions including lipodystrophy, MEN1, adrenal disorders, and hyperparathyroidism. Her obesity medicine certification means she handles weight and metabolic health as part of the same clinical picture, not as a separate referral.
Yes. Dr. Bansal holds board certification in three areas: Endocrinology, Diabetes and Metabolism (ABEM, 2022), Obesity Medicine (ABOM, 2023), and Internal Medicine (ABIM, 2018). She is also a Fellow of the American College of Endocrinology. Most physicians treating weight-related conditions hold certification in neither endocrinology nor obesity medicine. Dr. Bansal holds both.
Dr. Bansal earned her M.B.B.S. at B.J. Medical College in Pune, India, graduating as Gold Medalist. She completed her Internal Medicine residency at St. Joseph's Regional Medical Center and New York Medical College in Paterson, NJ. Her endocrinology fellowship took place at the National Institutes of Health within the NIDDK and NICHD divisions.
Dr. Bansal reads the full panel and tracks how markers move over time, not just whether a single value falls inside a reference range. She reviews every result a patient has previously had before the first visit. She also spends 45 minutes on patient history, treating the pattern of symptoms as clinical data in its own right.
Yes. Dr. Bansal frequently sees patients whose TSH falls within the reference range but who still experience symptoms. A single TSH value does not constitute a complete thyroid workup. She evaluates free T3, free T4, thyroid antibodies, and lab trajectories over time to build a fuller picture.
Dr. Bansal serves as Assistant Professor at Rutgers Robert Wood Johnson Medical School, where she leads the Metabolic and Weight-Management Clinic. She currently leads an IRB-approved study at Rutgers RWJMS investigating tirzepatide for treating insulin resistance in congenital generalised lipodystrophy. She has authored 13 peer-reviewed publications and presented research at ENDO, AACE, IASLC, and ISUOG.
Yes. Dr. Bansal considers this a core part of her practice. She tells patients clearly when their endocrine system is not the source of their symptoms and identifies the more appropriate clinician when that is the case. She applies the same standard to recommending Ongoing Care: she will say directly if a patient does not need it.
Yes. Dr. Bansal prescribes GLP-1 and dual-agonist therapies as part of her obesity medicine and metabolic health practice. She discusses medication costs with patients before prescribing. Medications are billed directly through the patient's pharmacy and Halt Clinic never marks them up.
Dr. Bansal gained her experience with rare endocrine conditions during her NIH fellowship, where she served as Co-Investigator on a long-term natural-history protocol in hyperparathyroidism and MEN1 syndrome. Her current research at Rutgers RWJMS focuses on lipodystrophy. She treats patients with adrenal disorders, hyperparathyroidism, MEN1, and lipodystrophy at Halt Clinic.
Doctor profile last updated November 1, 2026